Neurotoxicity is a rare and intolerable adverse effect associated with levofloxacin therapy, whose diagnosis has mostly been reported based on medical history rather than quantitative measures in the blood.
Masashi Nishikubo, Hiroaki Nishioka
exaly +4 more sources
Levofloxacin and Rifampin Resistance in Helicobacter pylori Isolates from Central-Western Colombia: Role of gyrA Mutations in Fluoroquinolone Resistance [PDF]
Background: Helicobacter pylori causes one of the most prevalent chronic bacterial infections worldwide. Data about H. pylori resistance rates to levofloxacin and rifampin (antimicrobials for second-, third- or fourth-line therapy) in Colombia and South ...
Adalucy Álvarez-Aldana +4 more
doaj +2 more sources
TXA11114: Discovery of an In Vivo Efficacious Efflux Pump Inhibitor (EPI) That Potentiates Levofloxacin Against Pseudomonas aeruginosa [PDF]
Objectives: Multidrug-resistant (MDR) Pseudomonas aeruginosa represents a major clinical challenge, driven in part by resistance–nodulation–division (RND) efflux pumps that reduce intracellular antibiotic concentrations and limit the efficacy of many ...
Jesus D. Rosado-Lugo +6 more
doaj +2 more sources
Shen-Peng Chang,1 Hong-Zin Lee,2 Chih-Cheng Lai,3 Hung-Jen Tang4 1Department of Pharmacy, Chi Mei Medical Center, Liouying, Taiwan; 2School of Pharmacy, China Medical University, Taichung, Taiwan; 3Department of Intensive Care Medicine, Chi Mei Medical ...
Chang SP, Lee HZ, Lai CC, Tang HJ
doaj +1 more source
PRODUCTION AND INVESTIGATION OF PROPERTIES OF LIPOSOMAL LEVOFLOXACIN
Liposomal levofloxacin was prepared with the extrusion technique. Levofloxacin is a fluoroquinolone used for resistant tuberculosis treatment. Traditional lipids such as phosphatidylcholine (PC), as well as a mixture of PC and cholesterol (Chol) were ...
G. М. Sorokoumova +7 more
doaj +1 more source
Chih-Wei Chen,1,2 Yu-Hung Chen,3 I-Ling Cheng,3 Chih-Cheng Lai41Division of Neurosurgery, Department of Surgery, Chi Mei Medical Center, Tainan, Taiwan; 2Department of Occupational Safety and Health, Institute of Industrial Safety and Disaster Prevention,
Chen CW, Chen YH, Cheng IL, Lai CC
doaj +1 more source
Update on the second-line treatment of infection: a narrative review
A standard bismuth quadruple therapy, a fluoroquinolone-containing triple (or quadruple) therapy or a proton pump inhibitor (PPI)-amoxicillin high-dose dual therapy has been recommended as a second-line treatment for Helicobacter pylori infection by the ...
Chih-An Shih +5 more
doaj +1 more source
Antibiotic resistance of Helicobacter pylori in the European part of the Russian Federation: first results [PDF]
Aim. Determine the primary antibiotic resistance of Helicobacter pylori (H. pylori) strains isolated from patients living in the European part of the Russian Federation. Materials and methods. As part of a clinical laboratory study, from 2015 to 2018,
I. V. Maev +15 more
doaj +1 more source
Synthesis a Number of Heterocyclic Compounds and some of chalcones Derived From Levofloxacin
The hydrazide (1) was used as synthone for the following Compound pyridazine-3,6-dione (2) by reaction of hydrazide (1) with maleic anhydride and Compound phthalazine-1,4-dione (3) by the reaction of hydrazide (1) with phthalic anhydride.
Ekram Abdullah Basheer +2 more
doaj +1 more source
Susceptibility-Guided Versus Empirical Therapy for Helicobacter pylori Infection in a High Resistance Setting: A Randomised Controlled Trial. [PDF]
In a randomised trial conducted in a high‐resistance region, PCR‐based susceptibility‐guided therapy showed no superiority over empirical therapy for Helicobacter pylori eradication. Empirical clarithromycin‐containing quadruple therapy remained effective despite high clarithromycin resistance.
Lu K +11 more
europepmc +2 more sources

